Man Group PLC Absci Corp Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.41 - $5.74 $298,647 - $502,709	87,580 Added 86.41%	188,935 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$1.15 - $4.79 $116,558 - $485,490	101,355 New	101,355 $425,000
Q4 2021 Feb 14, 2022	SELL	$7.88 - $18.03 $91,620 - $209,634	-11,627 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.37 - $30.29 $120,571 - $352,181	11,627 New	11,627 $135,000

127

59.1M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $249M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.